tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY

Allergy Therapeutics (AGY) Ownership - Who Owns Allergy Therapeutics?

4 Followers

Allergy Therapeutics (AGY) Ownership Overview

5.53%0.00%0.12%94.36%
0.12% Other Institutional Investors
94.36% Public Companies and
Individual Investors
The ownership structure of Allergy Therapeutics (GB:AGY) stock is a mix of institutional, retail and individual investors. Approximately 0.12% of the company’s stock is owned by Institutional Investors, 5.53% is owned by Insiders and 94.36% is owned by Public Companies and Individual Investors.
The ownership structure of Allergy Therapeutics (GB:AGY) stock is a mix of institutional, retail and individual investors. Approximately 0.12% of the company’s stock is owned by Institutional Investors, 5.53% is owned by Insiders and 94.36% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 10, 2023
Zheqing (simon) Shen
Non Executive,director, >10% Owner
Bought£2479351
Oct 13, 2023
Anthony Parker
Non Executive,director
Bought£16500
Oct 13, 2023
Peter Jensen
Chairman,director
Bought£18000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
243,661,071Insider5.11%6,944,341
5,033,109Insider0.11%143,444
5,001,200Insider0.10%142,534
3,347,669Insider0.07%95,409
2,100,000Insider0.04%59,850
1,360,000Insider0.03%38,760
776,513Insider0.02%22,131
532,160Insider0.01%15,167
510,658Insider0.01%14,554
388,262Insider<0.01%11,065

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Allergy Therapeutics PLC (GB:AGY)?
According to the latest TipRanks data, approximately 0.12% of the company's stock is held by institutional investors, 5.53% is held by insiders, and 94.36% is held by retail investors.
    What percentage of Allergy Therapeutics PLC (GB:AGY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.12% of Allergy Therapeutics PLC (GB:AGY) stock is held by institutional investors.
      What percentage of Allergy Therapeutics PLC (GB:AGY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 94.36% of Allergy Therapeutics PLC (GB:AGY) stock is held by retail investors.
        Who owns the most shares of Allergy Therapeutics PLC (GB:AGY)?
        Alejandro Esteban Weinstein Manieu owns the most shares of Allergy Therapeutics PLC (GB:AGY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis